Researchers find investigational agent reduces tumour resistance to breast cancer therapy
Wednesday, January 6, 2010 - 06:21
in Health & Medicine
Researchers at Georgetown Lombardi Comprehensive Cancer Centre have found a way to cleverly override signals that tell breast cancer cells to keep surviving in the face of anticancer treatment. The investigational agent they used renews the sensitivity of these breast cancer cells to treatment by fulvestrant (Faslodex(R)) which had stopped working...